Tulip Biosciences develops nature‑inspired biomaterials that mimic the body’s mucus barrier to restore and protect mucosal surfaces. Their proprietary mucin‑mimetic platform creates mucoadhesive, pH‑balancing glycopolymers that hydrate tissue, support a healthy microbiome, and reduce reliance on antibiotics, initially targeting women’s vaginal health and expanding to ocular, gut, and wound applications.
Funding
Funding not disclosed
Founders
Product
Problem
Many mucosal surfaces—particularly the vaginal tract—lose their natural mucus barrier due to aging, infection, or antibiotic use, leading to dryness, irritation, recurrent bacterial vaginosis, and increased reliance on antibiotics. Existing lubricants and treatments do not restore the underlying barrier and often disrupt the microbiome.
Solution
Tulip Biosciences leverages a proprietary mucin‑mimetic platform that recreates the key glycan chemistry and mucoadhesive properties of natural mucus. Their synthetic glycopolymers adhere to mucosal tissues, hydrate the surface, balance pH, and support a healthy microbial community without relying on antibiotics. By rebuilding the barrier, the platform aims to relieve dryness, reduce recurrence of bacterial vaginosis, and provide a foundation for microbiome‑friendly therapies across multiple mucosal sites, including the vagina, eyes, gut, and skin. The approach is presented as a scalable, nature‑inspired biomaterial class that can be formulated into products for women's health, ocular care, gut health, wound care, and non‑hormonal contraception.
Target Audience
Primary customers are women’s health clinicians, pharmaceutical and consumer‑health companies developing vaginal care, ocular lubricants, gut‑support products, and wound‑care solutions that require microbiome‑friendly barrier restoration.
Features
- Synthetic mucin‑mimetic glycopolymers that replicate natural mucus glycan motifs for selective microbial interaction and barrier protection
- Strong mucoadhesion and rheological properties that maintain hydration and form a stable protective film on mucosal tissues
- pH‑buffering capability to preserve the optimal environment for beneficial microbiota
- Antibiotic‑sparing formulation designed to reduce reliance on traditional antimicrobial drugs
- Platform versatility enabling adaptation for vaginal health, dry eye, gut barrier support, wound healing, and non‑hormonal contraception
- Scalable, biocompatible manufacturing process suitable for both clinical and consumer product formats